Businesstoday
HOME
ECONOMY
US lawmakers back India's move to raise FDI in insurance sector to 74%
COVID-19 in Delhi: Arvind Kejriwal to hold review meeting today; weekend lockdown begins in Delhi
India reports biggest daily spike of 2.34 lakh COVID-19 cases, 1,341 deaths
Delhi sees highest daily surge of 19,486 COVID-19 cases, 141 deaths
'Kumbh Mela should now only be symbolic,' says PM Modi
CORPORATE
NSE co-location case: SEBI slaps Rs 18 lakh fine on two trading members
Findoc Group to launch new app, expand services to Delhi NCR
Zomato turns a public company ahead of IPO
Wipro plans integration with Capco -- its biggest buy!
TCS fares better with lowest attrition rate; Infosys, Wipro lag
MARKETS
Sensex ends higher for third session; Asian Paints, UltraTech Cement, ONGC top gainers
Macrotech Developers IPO share allotment today: Here's how to check status
Ashoka Buildcon share rises 11% after firm wins project from Gujarat Rail Infrastructure
Why SBI Cards share rose over 7% today
Wipro share hits all-time high on strong Q4 earnings; here's what brokerages say
MONEY
National Pension System: PFRDA makes 5 key announcements
MFIs to face asset quality pressures in near term due to recent surge in COVID-19 cases: Icra
COVID-19 impact: Expect 15% hike in health insurance premium by next quarter
2800% returns YTD! What's happening with Dogecoin?
Ask Money Today: How to settle death cases under Atal Pension Yojana?
INDUSTRY
IndiGo to waive change fees on domestic tickets booked between Apr 17-30
NTPC to raise Rs 3,966 crore through non-convertible bonds next week
Honda recalls 78,000 cars in India to fix faulty pump
Maruti Suzuki hikes prices of select models from today; check out details
India to spend $200 million over next 5-7 years to promote hydrogen use
TECH
Telegram launches two new web apps with better features and design
Apple AirTags: Specs, features, launch date, India price, and everything we know so far
Google rolls out Chrome update with nifty features, serious performance upgrade
HP Smart Tank 530 review: Nifty, hassle-free printer
Google misled some Android and Pixel phone users in Australia about location data, court rules
OPINION
India's e-payments space: A dawn or down of retail in India?
How Millennials, Gen Z are shifting focus to balance in work life, not just work-life balance
WhatsApp leak case: Do companies need to root out the mole within
India badly needs Sputnik V in fight against COVID-19
How India can beat coronavirus faster
photos
Wholesale inflation jumps to 7.4% in March 2021
Weekend curfew in Delhi: What's open, what's not
FY21 - A forgettable fiscal for auto industry
COVID-19 India: The mutant strains we must know about
Net indirect tax receipts rise by 12.3% in FY21
Videos
03:17
Actual COVID cases in India can be 5-10 times higher: Expert
06:40
Groww to launch derivatives, US stock investment soon; insurance, lending in pipeline
01:12
PM takes stock of oxygen supply for next 15 days
02:49
RIL helps Maharashtra with oxygen ; Tokyo under 'quasi-emergency'
04:24
COVID-19: India records highest daily surge of over 2 lakh cases
MAGAZINE
May 2, 2021
April 18, 2021
April 4, 2021
March 21, 2021
March 7, 2021
Settings
Logout
BT SPECIALS
UNION BUDGET
SPECIAL ISSUES
SPECIAL REPORTS
BT BUZZ
SLOWDOWN BLUES
JOBS REALITY CHECK
WORLD ECONOMIC FORUM
LOK SABHA ELECTION 2019
REBRAIN OR ROT
EVENTS
MAGAZINE ARCHIVES
BUSINESS TODAY
MONEY TODAY
GADGETS AND GIZMOS
Home
Search
Total 473 results found. Search for
[ Zydus Cadila ]
Results 1 to 21 of 473
How much vaccines can India make? And the catch...
PB Jayakumar, Rai Vinaykumar
April 13, 2021
Indian vaccine manufacturers, including SII, Bharat Biotech, Panacea Biotech, Sanofi's Shanta Biotech, Biological E, Hester Biosciences and Zydus Cadila, have an installed capacity to manufacture 8.2 billion doses of different vaccines per year
Stocks in news: TCS, Infosys, Balrampur Chini Mills, Barbeque Nation and more
BusinessToday.In
April 12, 2021
Stocks in focus in today's trade: TCS, Infosys, Balrampur Chini Mills, Pharma stocks, Barbeque Nation Hospitality and more
Zydus' COVID-19 drug shows promise in Phase 3 trials; seeks DCGI nod
BusinessToday.In
April 5, 2021
Over 91.15% of patients treated with PegIFN were found to be RT PCR negative by day 7 as compared to 78.90 per cent on the 'standard of care' arm; PegIFN reduced the duration for supplemental oxygen to 56 hours from 84 hours in moderate COVID-19 patients
Stock in news: Reliance, Future Retail, Dalmia Bharat, Vedanta, SBI Cards
BusinessToday.In
April 5, 2021
Shares of Reliance, SBI, Future Retail, Dalmia Bharat, Vedanta, SBI Cards will be in focus in Monday's trading session
Stock in news: Craftsman, Laxmi Organic, Adani Green, Cadila, TVS Motors, Bank of India, Jubilant FoodWorks
BusinessToday.In
March 25, 2021
Shares of Craftsman Automation, Anupam Rasayan, Laxmi Organic Industries, Adani Green, Cadila, TVS Motors, Bank of India, Jubilant FoodWorks will be in focus in Thursday's trading session
Cadila Healthcare share rises over 1% after subsidiary announces settlement of patent litigation in US
BusinessToday.In
March 24, 2021
Share of Cadila Healthcare rose up to 1.15% to Rs 436.05 against previous close of Rs 431.05 on BSE
Zydus slashes COVID-19 drug Remdesivir price by over two-third; now costs Rs 899
BusinessToday.In
March 24, 2021
This move to further revise the prices will go a long way in helping patients during these critical times, the company said.
Share Market Highlights: Sensex ends 871 pts lower, Nifty at 14,549; M&M, SBI, IndusInd, Axis Bank leads fall
BusinessToday.In
March 24, 2021
Stock Market News Update Today: The BSE Sensex witnessed broader-based selling with 28 out of 30 BSE index heavyweights ending in red amid fear that second and third wave infections in India are bound to hamper economic recovery
Covaxin exceeds efficacy of most traditional platform-based COVID-19 vaccines
PB Jayakumar
March 3, 2021
So far, the Pfizer-BioNTtech and Moderna vaccines, made through a novel platform technology never used in humans before, are proven to have maximum efficacy
Indian pharma grows for 5th straight month; sales rise 4.5% in January
Niti Kiran
February 11, 2021
Growth in the Indian pharma market is expected to be linear ahead. The market has now grown for the fifth consecutive month and the momentum is likely to improve
First new chemical entity discovered by Indian scientists gets USFDA approval
PB Jayakumar
February 9, 2021
Rhizen has retained commercialisation rights for India while also being the manufacturing and supply partner for Umbralisib. Alembic owns 50 per cent stake in Rhizen
Zydus Cadila net profit rises 41% to Rs 527 cr in Q3
BusinessToday.In
February 5, 2021
Cadila says its business in India, which comprises human health formulations, consumer wellness and animal health, posted strong growth during the quarter as it rose 20 per cent on a y-o-y basis and recorded revenues of Rs 1,643 crore
Don't worry! 63 COVID-19 vaccines in pipeline, another 173 in the works
PB Jayakumar
January 27, 2021
COVID-19 vaccine: About 19 vaccines are going to be globally available in the coming few weeks and months. Of this, about nine have already got emergency use authorisation
Stocks in news: RIL, YES Bank, JM Financial, Gland Pharma, JSW Steel, Tata Motors
BusinessToday.In
January 25, 2021
Stocks to watch today on January 25: RIL, YES Bank, JM Financial, Gland Pharma, JSW Steel, Tata Motors among others are the top stocks to watch out for in Monday's trading session
Zydus Cadila gets US health regulator's nod for thyroid drug
PTI
January 23, 2021
Zydus Cadila has received final approval from the US Food and Drug Administration (USFDA) to market Liothyronine Sodium tablets USP, 5 mcg, 25 mcg, and 50 mcg, Cadila Healthcare said in a regulatory filing
Phase 1 trial of Covaxin shows enhanced immunity, no serious side effects: Lancet
PTI
January 22, 2021
There were no serious side effects in the participants enrolled for the phase 1 trial of Covaxin, according to the results published in The Lancet
Four more COVID-19 vaccines on cards in India, check prices here
BusinessToday.In
January 12, 2021
Among these vaccines are those developed by Zydus Cadila, Biological E and Gennova, along with Russia's Sputnik-V vaccine
10% COVID-19 vaccines will be wasted, says Centre; to cost Rs 1,320 crore more
Manoj Sharma | Mudit Kapoor
January 7, 2021
Initial 30 crore vaccinations (60 crore doses) planned by the Centre would have cost Rs 13,200 crore. However, need for 66 crore doses raises the cost by Rs 1320 crore
How Zydus Wellness is trying to regain Complan's lost glory
Ajita Shashidhar
January 7, 2021
Tarun Arora, CEO, Zydus Wellness said that the company, to begin with, is investing massively to improve the penetration of the Complan brand in mass markets
All Indian COVID-19 vaccines have to be stored at 2-8 degrees Celsius: DBT
PTI
January 6, 2021
(For) all our vaccines, we are looking at right now..(we) are targeting 2-8 degree because our logistics are worked out on that basis and we are working on that, DBT secretary Renu Swarup said at a press briefing
PAGES 1 OF 24
1
2
3
4
5
Advertisement
LATEST
Must Read
TECH NEWS
US lawmakers back India's move to raise FDI in insurance sector to 74%
Kerala lottery result 17.04.2021: 'Karunya Plus KR 495' weekly lottery winners announce timings today; where and when to check online
COVID-19 in Delhi: Arvind Kejriwal to hold review meeting today; weekend lockdown begins in Delhi
India reports biggest daily spike of 2.34 lakh COVID-19 cases, 1,341 deaths
Punjab-origin woman among injured in FedEx shooting in US
More
Reliance Jio Prime vs Airtel, Vodafone, Idea 4G offers
Reliance Jio plans to bring 5G internet to your smartphones
Maruti Suzuki opens online booking for Baleno RS
India Inc to get 9.5 per cent salary hike this year
Five tips to get a good salary hike this year
Telegram launches two new web apps with better features and design
Apple AirTags: Specs, features, launch date, India price, and everything we know so far
Google rolls out Chrome update with nifty features, serious performance upgrade
New Kindle update will let you set your current book cover as lockscreen
Google misled some Android and Pixel phone users in Australia about location data, court rules
More